1Kassell NF,Boarini DJ,Adams HP,et al.Overall management of ruptured aneurysm:comparison of early and late operationf[J].Neurosurgery,1981,9(2):120-128.
2Lennihan L,Mayer SA,Fink ME,et al.Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage:a randomized controlled trial[J].Stroke,2000,31(2):383-391.
3Treggiari MM,Walder B,Suter PM,et al.Systematic review of the prevention of delayed ischemic neurological deficits with hypertension,hypervolemia,and hemodilution therapy following subarachnoid hemorrhage[J].J Neurosurg,2003,98(5):978-984.
4Sen J,Belli A,Albon H,et al.Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage[J].Lancet Neurol,2003,2(10):614-21.
5Gupta D,Sharma BS,Gupta SK,et al.Postoperative hy-pertensive-hypervolaemic-haemodilution(Triple H)therapy in the treatment of vasospasm following aneurysmal subarachnoid haemorrhage[J].Neurol India,2000,48(2):126-131.
6Bederson JB,Connolly ES Jr,Batjer HH,et al.Guidelines for the management of aneurysmal subarachnoid hemorrhage:a statement for healthcare professionals from a special writing group of the Stroke Council,American Heart Association[J].Stroke,2009,40(3):994-1025.
7Deshaies EM,Boulos AS,Popp AJ.Peri-operative medical management of cerebral vasospasm[J].Neurol Res,2009,31(6):644-650.
8Treggiari MM,Deem S.Which H is the most important in triple-H therapy for cerebral vasospasm?[J].Curr Opin Crit Care,2009,15(2):83-86.
